Molecular dissection of mouse soluble guanylyl cyclase α1 promoter

被引:13
|
作者
Vazquez-Padron, RI [1 ]
Pham, SM
Pang, MH
Li, S
Aïtouche, A
机构
[1] Miami Univ, Dept Surg, Miami, FL USA
[2] Miami Univ, Vasc Biol Inst, Miami, FL USA
关键词
soluble guanylyl cyclase; promoter; dinucleotide microsatellites; transcriptional regulation; UTR regions;
D O I
10.1016/j.bbrc.2003.12.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble guanylyl cyclase (sGC) is the only known receptor for nitric oxide (NO) and is downregulated in aging and hypertension. Little is known about sGC gene transcriptional regulation. In order to characterize the sGC transcriptional system, we cloned and sequenced the 5' flanking region of mouse sGC a(1) gene (AY116663). Structurally, it is a non-canonical TATA-less promoter that we mapped to chromosome 3 with many putative regulation sites for Sp-1, NF-kappaB, and AP-1 transcription factors amongst others, and two (TG:CA)(n) dinucleotide microsatellites near the transcriptional start point. The cloned upstream sequence produced a 5-fold increase in luciferase activity in Cos7, HeLa, NIH3T3, and 293 cells as well as in mouse VSMC-like kidney mesangial cells. In the latter cell type, we showed that sGC alpha(1) promoter activity was dependent on the presence of its 5' unstranslated region (5'UTR). (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [31] Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone
    Detremmerie, Charlotte
    Vanhoutte, Paul M.
    Leungn, Susan
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (04) : 401 - 408
  • [32] Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity
    Serfas, L
    Burstyn, JN
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 359 (01) : 8 - 16
  • [33] Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase
    Schmidt, P
    Schramm, M
    Schröder, H
    Stasch, JP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 468 (03) : 167 - 174
  • [34] A novel insight into the molecular mechanism of human soluble guanylyl cyclase focused on catalytic domain in living cells
    Li, Jiannan
    Zhou, Yajun
    Lin, Ying-Wu
    Tan, Xiangshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 604 : 51 - 56
  • [35] RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase
    Sharina, Iraida G.
    Cote, Gilbert J.
    Martin, Emil
    Doursout, Marie-Francoise
    Murad, Ferid
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 25 (03): : 265 - 274
  • [36] Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm
    Martin, Emil
    Golunski, Eva
    Laing, Susan T.
    Estrera, Anthony L.
    Sharina, Iraida G.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 307 (11): : H1565 - H1575
  • [37] Cloning and functional expression of the rat α2 subunit of soluble guanylyl cyclase
    Koglin, M
    Behrends, S
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1494 (03): : 286 - 289
  • [38] Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice
    Olivencia, Miguel A. A.
    de Biedma-Elduayen, Leticia Gil
    Gimenez-Gomez, Pablo
    Barreira, Bianca
    Fernandez, Argentina
    Angulo, Javier
    Colado, Maria Isabel
    O'Shea, Esther
    Perez-Vizcaino, Francisco
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (18) : 2361 - 2376
  • [39] β-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells
    Baltrons, MA
    Pedraza, CE
    Heneka, MT
    García, A
    NEUROBIOLOGY OF DISEASE, 2002, 10 (02) : 139 - 149
  • [40] Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis
    Tsou, C. -Y.
    Chen, C. -Y.
    Zhao, J. -F.
    Su, K. -H.
    Lee, H. -T.
    Lin, S. -J.
    Shyue, S. -K.
    Hsiao, S. -H.
    Lee, T. -S.
    ACTA PHYSIOLOGICA, 2014, 210 (04) : 799 - 810